$辉瑞(PFE)$ _老虎社区_美港股上老虎

$辉瑞(PFE)$ 上半年全球药品销售榜单出炉，在GLP-1（胰高血糖素样肽-1，此类别药品主要用于治疗糖尿病与减重适应证）类药品激战之下，今年的“药王”之争依然充满悬念

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":466540469756288,"tweetId":"466540469756288","gmtCreate":1754927081639,"gmtModify":1754931763893,"author":{"id":4136426194875310,"idStr":"4136426194875310","authorId":4136426194875310,"authorIdStr":"4136426194875310","name":"天蓝色的市场","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$&nbsp;</a> 上半年全球药品销售榜单出炉，在GLP-1（胰高血糖素样肽-1，此类别药品主要用于治疗糖尿病与减重适应证）类药品激战之下，今年的“药王”之争依然充满悬念</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/PFE\">$辉瑞(PFE)$&nbsp;</a> 上半年全球药品销售榜单出炉，在GLP-1（胰高血糖素样肽-1，此类别药品主要用于治疗糖尿病与减重适应证）类药品激战之下，今年的“药王”之争依然充满悬念</p></body></html>","text":"$辉瑞(PFE)$ 上半年全球药品销售榜单出炉，在GLP-1（胰高血糖素样肽-1，此类别药品主要用于治疗糖尿病与减重适应证）类药品激战之下，今年的“药王”之争依然充满悬念","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/466540469756288","repostId":0,"isVote":1,"tweetType":1,"viewCount":803,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PFE"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":147,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/466540469756288"}